IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer announced the delivery and rigging of the C230 cyclotron at the new Apollo Proton Cancer Centre in Chennai, India. IBA will equip the centre in Chennai with a Proteus®PLUS* multi-room configuration, consisting of two gantry treatment rooms, and one fixed beam treatment room. Each room will be fitted with the most advanced Pencil Beam Scanning and Cone Beam CT (CBCT) technology; as well as the Philips Ambient Experience, an interactive, patient-focused healthcare environment that uses modern technology to create a more comfortable and soothing environment for treatment.
The Apollo Proton Cancer Centre is scheduled to treat its first patient in September 2018. Ion Beam Applications has collaborated with Philips India for the Apollo Hospitals Group project. This alliance combines IBA’s strengths in proton therapy and Philips expertise in clinical informatics.
Mr. Manoj Sahasrabudhe, Chief Operating Officer, IBA Proton Therapy, commented: “With forty-seven proton therapy systems sold worldwide, and more than half of all installed treatment rooms supplied by IBA, we are the clear leader in proton therapy. We are proud to be working with Apollo Hospitals and Philips, India to create a world class proton therapy facility in Chennai; a first for India. This state of the art centre will offer cancer patients in India and South-East Asia local access to this advanced cancer treatment.”
Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group, added: “As Asia’s trusted healthcare provider and a wholly patient-centric organization, we have continuously pioneered the introduction of cutting edge medical advancements to the region, with a view to leave no stone unturned in saving lives. The upcoming state-of-the-art 150-bed Apollo Proton Cancer Centre will be on par with the best Oncology centres in the world, enabling us to provide comprehensive cancer care to all our patients. With the first Proton Therapy centre in South Asia, this hospital will be accessible to over 3 billion people. Our battle against cancer has spanned over two decades, has witnessed several milestones, and has set new benchmarks in cancer care. Apollo has always been the first to bring the very best in oncology care to India. Now, the Apollo Proton Cancer Centre will bring about a transformative shift in cancer care and we look forward to treating the first patient by early September 2018.”
